Form 4: Director Anthony Semedo Receives Artivion Equity Grant

Artivion, Inc. director Anthony B. Semedo was granted 7,576 shares of common stock as part of an equity incentive plan.

Summary

• Director Anthony B. Semedo acquired 7,576 shares of Artivion, Inc. (AORT) common stock.
• The shares were granted at a price of $0, representing an equity incentive award.
• The grant is subject to a vesting schedule with a date of May 18, 2027.
• Following this transaction, Mr. Semedo directly owns 46,960 shares and indirectly owns 600 shares through his spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which is neutral in terms of market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increased total beneficial ownership for the director.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The granted shares are scheduled to vest on May 18, 2027, under the terms of the company's Equity and Cash Incentive Plan.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to align leadership incentives with long-term shareholder value in the medical device sector.

Comparison to Industry Standards

• The use of restricted stock awards (RSAs) for director compensation is consistent with standard practices among mid-cap medical technology companies.
• The vesting period of one year is a common retention mechanism for board members.

Stakeholder Impact

• Shareholders benefit from the alignment of director incentives with company performance.

Next Steps

• Vesting of the 7,576 shares on May 18, 2027.

Key Dates

Keywords

Artivion, AORT, Form 4, Insider Trading, Equity Incentive Plan, Director Compensation